[
  {
    "title": "J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease",
    "published": 1742560080
  },
  {
    "title": "3 Dividend Stocks to Buy for Reliable Passive Income",
    "published": 1742383800
  },
  {
    "title": "AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer",
    "published": 1742207191
  },
  {
    "title": "1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction",
    "published": 1742163540
  },
  {
    "title": "Q4 2024 Regenxbio Inc Earnings Call",
    "published": 1741959544
  },
  {
    "title": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "published": 1741944600
  },
  {
    "title": "Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%",
    "published": 1741795343
  },
  {
    "title": "VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply",
    "published": 1741781880
  },
  {
    "title": "Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.",
    "published": 1741777800
  }
]